631 related articles for article (PubMed ID: 34789332)
1. New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis.
Theunissen F; West PK; Brennan S; Petrović B; Hooshmand K; Akkari PA; Keon M; Guennewig B
Transl Neurodegener; 2021 Nov; 10(1):46. PubMed ID: 34789332
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
[TBL] [Abstract][Full Text] [Related]
3. Axonal transport and neurodegenerative disease.
Chevalier-Larsen E; Holzbaur EL
Biochim Biophys Acta; 2006; 1762(11-12):1094-108. PubMed ID: 16730956
[TBL] [Abstract][Full Text] [Related]
4. Disruption of axonal transport in neurodegeneration.
Berth SH; Lloyd TE
J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37259916
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis.
Cunha-Oliveira T; Montezinho L; Simões RF; Carvalho M; Ferreiro E; Silva FSG
Cells; 2024 Jan; 13(3):. PubMed ID: 38334639
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial diseases of the brain.
Chaturvedi RK; Flint Beal M
Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
[TBL] [Abstract][Full Text] [Related]
7. Neuron-glia interactions underlie ALS-like axonal cytoskeletal pathology.
King AE; Dickson TC; Blizzard CA; Woodhouse A; Foster SS; Chung RS; Vickers JC
Neurobiol Aging; 2011 Mar; 32(3):459-69. PubMed ID: 19427060
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS.
Kawamata H; Manfredi G
Mech Ageing Dev; 2010; 131(7-8):517-26. PubMed ID: 20493207
[TBL] [Abstract][Full Text] [Related]
9. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
Olesen MA; Villavicencio-Tejo F; Quintanilla RA
Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
[TBL] [Abstract][Full Text] [Related]
10. A novel hypothesis on metal dyshomeostasis and mitochondrial dysfunction in amyotrophic lateral sclerosis: Potential pathogenetic mechanism and therapeutic implications.
Nakagawa Y; Yamada S
Eur J Pharmacol; 2021 Feb; 892():173737. PubMed ID: 33220280
[TBL] [Abstract][Full Text] [Related]
11. Multiple roles for the cytoskeleton in ALS.
Liu X; Henty-Ridilla JL
Exp Neurol; 2022 Sep; 355():114143. PubMed ID: 35714755
[TBL] [Abstract][Full Text] [Related]
12. The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS.
Obrador E; Salvador-Palmer R; López-Blanch R; Jihad-Jebbar A; Vallés SL; Estrela JM
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198557
[TBL] [Abstract][Full Text] [Related]
13. The Role of Bioenergetics in Neurodegeneration.
Strope TA; Birky CJ; Wilkins HM
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012480
[TBL] [Abstract][Full Text] [Related]
14. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.
Parone PA; Da Cruz S; Han JS; McAlonis-Downes M; Vetto AP; Lee SK; Tseng E; Cleveland DW
J Neurosci; 2013 Mar; 33(11):4657-71. PubMed ID: 23486940
[TBL] [Abstract][Full Text] [Related]
15. Miro (Mitochondrial Rho GTPase), a key player of mitochondrial axonal transport and mitochondrial dynamics in neurodegenerative diseases.
Panchal K; Tiwari AK
Mitochondrion; 2021 Jan; 56():118-135. PubMed ID: 33127590
[TBL] [Abstract][Full Text] [Related]
16. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis.
Riancho J; Gonzalo I; Ruiz-Soto M; Berciano J
Neurologia (Engl Ed); 2019; 34(1):27-37. PubMed ID: 26853842
[TBL] [Abstract][Full Text] [Related]
17. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis.
Collard JF; Côté F; Julien JP
Nature; 1995 May; 375(6526):61-4. PubMed ID: 7536898
[TBL] [Abstract][Full Text] [Related]
18. Role of mitochondria in amyotrophic lateral sclerosis.
Swerdlow RH; Parks JK; Pattee G; Parker WD
Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1(3):185-90. PubMed ID: 11464951
[TBL] [Abstract][Full Text] [Related]
19. TDP-43 and Cytoskeletal Proteins in ALS.
Oberstadt M; Claßen J; Arendt T; Holzer M
Mol Neurobiol; 2018 Apr; 55(4):3143-3151. PubMed ID: 28466273
[TBL] [Abstract][Full Text] [Related]
20. The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders.
Eira J; Silva CS; Sousa MM; Liz MA
Prog Neurobiol; 2016 Jun; 141():61-82. PubMed ID: 27095262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
